checkAd

     181  0 Kommentare AYURCANN REPORTS RECORD SALES OF $5,893,351 FOR Q3 2023, AN INCREASE OF 114% OVER Q3 2022 - Seite 2

    “With our laser focus on growth, market share and innovation, combined with our current product offerings, we are confident that we can continue to bring offerings to market, grow market share and sales across the country, increasing our top line revenues,” further added Mr. Sudman.

    For further information, please contact:

    Igal Sudman, Chairman and Chief Executive Officer
    Ayurcann Holdings Corp.
    Tel: 905-492-3322.
    Email: info@ayurcann.com

    Investor Relations:

    Email: ir@ayurcann.com

    About Ayurcann:

    Ayurcann is a leading post-harvest cannabis product manufacturer with a focus on providing and creating new innovations in the adult use cannabis industry in Canada. Ayurcann is striving to become a top supplier of Canadian cannabis brands.

    For more information about Ayurcann, please visit www.ayurcann.com and its profile page on SEDAR at www.sedar.com.

    Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

    Cautionary Note Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as plans, strategy, expects or does not expect, intends, continues, anticipates or does not anticipate, or believes, or variations of such words and phrases or may contain statements that certain actions, events or results will be taken, will launch or will be launching, will include, will allow, will be made will continue, will occur or will be achieved. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the growth trajectory of the Company’s revenue and in-house brands having a positive impact on the Company’s future development; the Company launching new SKUs upon the timelines disclosed herein; the Company bringing offerings to market, gaining market share and sales across the country, allowing the Company to grow its revenue; and the ability of the Company to elevate within the industry and become an industry leader.

    Seite 2 von 4


    Diskutieren Sie über die enthaltenen Werte


    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    AYURCANN REPORTS RECORD SALES OF $5,893,351 FOR Q3 2023, AN INCREASE OF 114% OVER Q3 2022 - Seite 2 Toronto, Ontario, May 29, 2023 (GLOBE NEWSWIRE) - Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis company specializing in the processing and manufacturing of cannabis 2.0 and …